November 8, 2016 / 3:03 PM / in a year

BUZZ-Valeant Pharmaceuticals: Hits 6-year low on forecast cut

(Updates)

** Canadian drugmaker’s U.S. shares plunge as much as 28 pct to more than 6-year low of $13.77; Biggest intraday pct drop since March

** Company reports lower-than-expected Q3 adj profit, slashes FY profit and revenue forecasts

** Shares of other specialty drugmakers also fall: Mylan NV 2.9 pct, Teva Pharmaceutical International Ltd’s U.S. shares 3 pct

** Valeant’s Toronto-listed stock down 25.7 pct at C$19

** Up to Monday’s close, VRX U.S. stock had lost 93 pct since its 2015 August record high of $263.81 as the company’s pricing and business practices started to come under intense scrutiny from politicians and regulators

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below